Skip to main content
. 2015 Jan 27;32(1):69–85. doi: 10.1007/s12325-015-0180-x

Fig. 5.

Fig. 5

Cost-effectiveness acceptability curve: current practice compared to GP plus CRP. Three-year time horizon, 100 patients and discounted costs and QALYs. 5,000 iterations. CRP C-reactive protein, GP general practitioner, NMB net monetary benefit, QALYs quality-adjusted life years